Brokerages Set Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Target Price at $21.00
Shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued a report on the […]
Shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued a report on the […]
